Page 6 of 18 Reference: Marilen Cabrera, RN Home Health Care Chicago, MN

Case study 3: Stage III sacral pressure injury

Day 0. Day 4.

Day 7. Day 14.

Enluxtra™ Self-Adaptive Wound Dressing Clinical Results

Patient: A 107-year-old female admitted to Home Health Agency.

Wound and previous treatment: Stage III sacral pressure injury. The wound is recurring, periwound is mostly fragile scar tissue from previously healed wounds in the same location. Prior to admission to HHA, pad dressings were applied to the wound.

Day 14: Wound size is 1.5cm x 2cm x 0.1cm. Minimal drainage and pain, no odor.

Day 7: Wound size continues to decrease; 3cm x 5cm x 0.2cm.

Day 4: Significant reduction of wound size to 4cm x 7cm x 0.2cm. Drainage and odor are minimal. Pain is 5 out of 10.

At presentation: Wound size is 15cm x 12cm x 0.2cm. Moderate drainage and odor. Pain is 8 out of 10.

Enluxtra treatment: Enluxtra dressing treatment was started immediately with changes 2 times per week. A turning schedule was initiated.

Conclusions and clinical outcome:

This case demonstrates the importance of starting Enluxtra treatment early. This recurring wound in a vulnerable location with skin prone to breakage due to ageing and loss of elasticity had a potential of quick worsening and progressing to Stage IV, which would raise various risks for this very elderly patient.

Quick healing achieved with Enluxtra dressings has prevented many expensive and potentially dangerous treatment options with unpredictable outcomes.

The wound was completely closed after only 4 Enluxtra dressing changes.

Additionally, the patient has beenprovided with comfort and non-medicated pain relief without any side effects that might have further compromised the patient’s fragile health at this stage of life.